Opioid drug tolerance develops from interplay of key gene and cholesterol
The most effective pain relievers lose power over time. Scientists discover a gene that controls cholesterol in the cell membrane plays a key role.
The most effective pain relievers lose power over time. Scientists discover a gene that controls cholesterol in the cell membrane plays a key role.
More than 30 high school and undergraduate students interned at UF Scripps during the summer of 2022, learning wet lab skills, data science and molecular biology, all thanks to the William R. Kenan, Jr. Charitable Trust and the National Science Foundation.
When a virus infects a cell, it has one goal: hijack the cell’s protein-building systems to make new copies of itself. Biochemist James M. Burke, Ph.D. has joined the molecular medicine department at UF Scripps to advance studies of viral infection and innate immunity.
Ciaran Seath, Ph.D. studies protein interactions in cells, using light to better understand disease and the effects of medications. He is joining the UF Scripps Chemistry Department. Promising new drugs sometimes fail when they reach clinical trials despite strong early data. A new scientist joining UF Scripps Biomedical Research aims…
The nation’s medicine chest needs more options for treating dangerous viral diseases. UF Scripps scientists will receive an estimated $15 million to join in a massive federal effort to develop new medicines against COVID and other viruses.
The findings show it is possible to substantially accelerate the drug discovery process. The technique opens new doors to treating diseases by targeting their RNA processes, said Disney.
As the new CFO for UF Scripps, Lapple will provide strategic direction, guidance and oversight for the institute’s important mission of advancing scientific discovery and education for the betterment of human health.
Two of the nation’s most respected research institutions have closed their transaction that adds a Florida powerhouse meant to accelerate the pace of biomedical discoveries that benefit patients.
Nanotube tunnels that act like roadways capable of transporting cargo between cells can transmit a toxic protein linked to Huntington’s disease, a new study finds.
As cells are building proteins, the process is occasionally halted in error prior to completion. How cells sense these glitches is clearer thanks to Joazeiro lab.